Details for 2009814951

Up to date per 03.04.2026

Actions

Title / Product Name

EINE KOMBINATION AUS EINEM TNF-ALPHA-HEMMER, EINEM IAP-BLOCKER UND EINEM AGONISTEN DES TRAIL-REZEPTORS ZUR VERWENDUNG IN DER BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2009814951

EP Publication Number

2350641

E-Number

688297

Language

PCT Number

US09052789

Publication Date

03.08.2011 A

24.09.2014 B1

Registration Date

24.09.2014

AT Publication Date

15.10.2014

Application Date

05.08.2009

Registration Number

Priorities

22.09.2008

99088 P

IPC

A61K 38/17 20060101AFI20140205BHEP

Maximum Duration of Protection

05.08.2029

Owner

Amgen Inc.One Amgen Center Drive M/S 28-2-C Thousand Oaks, CA 91320-1799US

Tetralogic Pharmaceuticals Corporation343 Phoenixville Pike Malvern, PA 19355US

Representative

No representatives present

Inventor

HOLLAND, Pamela, M.c/o Amgen Inc. One Amgen Center Drive Mail Stop 28-2-C Thousand Oaks, CA 91320-1799US

PIASECKI, Julia, C.c/o Amgen Inc One Amgen Center Drive Mail Stop 28-2-C Thousand Oaks, CA 91320-1799US

BENETATOS, Christopher, A.c/o Tetralogic Pharmaceuticals 314 Phoenixville Pike Malvern, PA 19355US

CHUNDURU, Srinivas, K.c/o Tetralogic Pharmaceuticals 343 Phoenixville Pike Malvern, PA 91355US

MCKINLAY, Mark, A.c/o Tetralogic Pharmaceuticals 343 Phoenixville Pike Malvern, PA 19355US